Trials / Available
AvailableNCT05619367
A Compassionate Use (CU) Program of Odronextamab
- Status
- Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- Regeneron Pharmaceuticals · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- —
Summary
Provide compassionate use of odronextamab
Conditions
- Relapsed or Refractory (R/R) Follicular Lymphoma (FL)
- Diffuse Large B-Cell Lymphoma (DLBCL)
- B-Cell Non-Hodgkin Lymphoma (NHL)
- High-Grade B-Cell Lymphoma (HGBCL)
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Odronextamab |
Timeline
- First posted
- 2022-11-16
- Last updated
- 2025-12-23
Source: ClinicalTrials.gov record NCT05619367. Inclusion in this directory is not an endorsement.